Warning: The NCBI web site requires JavaScript to function. more...
Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer.
Li J, Eriksson L, Humphreys K, Czene K, Liu J, Tamimi RM, Lindström S, Hunter DJ, Vachon CM, Couch FJ, Scott CG, Lagiou P, Hall P.
Breast Cancer Res. 2010;12(2):R19. Epub 2010 Mar 9.
Related citations
Multi-variant pathway association analysis reveals the importance of genetic determinants of estrogen metabolism in breast and endometrial cancer susceptibility.
Low YL, Li Y, Humphreys K, Thalamuthu A, Li Y, Darabi H, Wedrén S, Bonnard C, Czene K, Iles MM, Heikkinen T, Aittomäki K, Blomqvist C, Nevanlinna H, Hall P, Liu ET, Liu J.
PLoS Genet. 2010 Jul 1;6(7):e1001012.
Breast cancer susceptibility loci and mammographic density.
Tamimi RM, Cox D, Kraft P, Colditz GA, Hankinson SE, Hunter DJ.
Breast Cancer Res. 2008;10(4):R66. Epub 2008 Aug 5.
Common genetic variation of insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, and acid labile subunit in relation to serum IGF-I levels and mammographic density.
Taverne CW, Verheus M, McKay JD, Kaaks R, Canzian F, Grobbee DE, Peeters PH, van Gils CH.
Breast Cancer Res Treat. 2010 Oct;123(3):843-55. Epub 2010 Feb 14.
Association between breast cancer susceptibility loci and mammographic density: the Multiethnic Cohort.
Woolcott CG, Maskarinec G, Haiman CA, Verheus M, Pagano IS, Le Marchand L, Henderson BE, Kolonel LN.
Breast Cancer Res. 2009;11(1):R10. Epub 2009 Feb 21.
Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study.
Tamimi RM, Cox DG, Kraft P, Pollak MN, Haiman CA, Cheng I, Freedman ML, Hankinson SE, Hunter DJ, Colditz GA.
Breast Cancer Res. 2007;9(1):R18.
Common genetic variants associated with breast cancer and mammographic density measures that predict disease.
Odefrey F, Stone J, Gurrin LC, Byrnes GB, Apicella C, Dite GS, Cawson JN, Giles GG, Treloar SA, English DR, Hopper JL, Southey MC; Australian Twins and Sisters Mammographic Density Study.
Cancer Res. 2010 Feb 15;70(4):1449-58. Epub 2010 Feb 9.
Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density.
Biong M, Gram IT, Brill I, Johansen F, Solvang HK, Alnaes GI, Fagerheim T, Bremnes Y, Chanock SJ, Burdett L, Yeager M, Ursin G, Kristensen VN.
BMC Med Genomics. 2010 Mar 19;3:9.
Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
Tamimi RM, Byrne C, Colditz GA, Hankinson SE.
J Natl Cancer Inst. 2007 Aug 1;99(15):1178-87. Epub 2007 Jul 24.
Breast cancer risk associated with genotypic polymorphism of the genes involved in the estrogen-receptor-signaling pathway: a multigenic study on cancer susceptibility.
Yu JC, Hsu HM, Chen ST, Hsu GC, Huang CS, Hou MF, Fu YP, Cheng TC, Wu PE, Shen CY.
J Biomed Sci. 2006 May;13(3):419-32. Epub 2006 Feb 25.
Joint effect of estrogen receptor beta sequence variants and endogenous estrogen exposure on breast cancer risk in Chinese women.
Zheng SL, Zheng W, Chang BL, Shu XO, Cai Q, Yu H, Dai Q, Xu J, Gao YT.
Cancer Res. 2003 Nov 15;63(22):7624-9.
Polymorphism of cytosolic serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan.
Cheng CW, Yu JC, Huang CS, Shieh JC, Fu YP, Wang HW, Wu PE, Shen CY.
Breast Cancer Res Treat. 2008 Sep;111(1):145-55. Epub 2007 Sep 22.
Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels.
Diorio C, Brisson J, Bérubé S, Pollak M.
Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):880-8.
Genetic analysis of mammographic breast density in adult women: evidence of a gene effect.
Pankow JS, Vachon CM, Kuni CC, King RA, Arnett DK, Grabrick DM, Rich SS, Anderson VE, Sellers TA.
J Natl Cancer Inst. 1997 Apr 16;89(8):549-56.
Mammographic density and candidate gene variants: a twins and sisters study.
Stone J, Gurrin LC, Byrnes GB, Schroen CJ, Treloar SA, Padilla EJ, Dite GS, Southey MC, Hayes VM, Hopper JL.
Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1479-84.
Are breast density and bone mineral density independent risk factors for breast cancer?
Kerlikowske K, Shepherd J, Creasman J, Tice JA, Ziv E, Cummings SR.
J Natl Cancer Inst. 2005 Mar 2;97(5):368-74.
Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer.
Khan QJ, Kimler BF, O'Dea AP, Zalles CM, Sharma P, Fabian CJ.
Breast Cancer Res. 2007;9(3):R35.
Decreased TGFbeta signaling and increased COX2 expression in high risk women with increased mammographic breast density.
Yang WT, Lewis MT, Hess K, Wong H, Tsimelzon A, Karadag N, Cairo M, Wei C, Meric-Bernstam F, Brown P, Arun B, Hortobagyi GN, Sahin A, Chang JC.
Breast Cancer Res Treat. 2010 Jan;119(2):305-14. Epub 2009 Feb 25.
Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
Chiarelli AM, Kirsh VA, Klar NS, Shumak R, Jong R, Fishell E, Yaffe MJ, Boyd NF.
Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1856-62.
Is there a difference in the association between percent mammographic density and subtypes of breast cancer? Luminal A and triple-negative breast cancer.
Ma H, Luo J, Press MF, Wang Y, Bernstein L, Ursin G.
Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):479-85. Epub 2009 Feb 3.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on